Dr. Meyer’s research focuses upon the differentiation of retinal ganglion cells from human pluripotent stem cells, including the derivation of glaucoma models through iPS cell reprogramming as well as Crispr/Cas9 gene editing.
Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.